Trial Profile
Phase IIa,Open Label,Multicenter Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs SB (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Mar 2011 New trial record